---
category: news
title: "BioXcel Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update"
excerpt: "Complete NDA submission forÂ BXCL501 for the acute treatment of agitation in patients with schizophrenia and bipolar disorders on track for Q1"
publishedDateTime: 2020-11-12T12:13:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/bioxcel-therapeutics-reports-third-quarter-2020-financial-results-and-provides-business-update-1029795792"
webUrl: "https://markets.businessinsider.com/news/stocks/bioxcel-therapeutics-reports-third-quarter-2020-financial-results-and-provides-business-update-1029795792"
ampWebUrl: "https://markets.businessinsider.com/amp/news/BioXcel-Therapeutics-Reports-Third-Quarter-2020-Financial-Results-and-Provides-Business-Update-1029795792"
cdnAmpWebUrl: "https://markets-businessinsider-com.cdn.ampproject.org/c/s/markets.businessinsider.com/amp/news/BioXcel-Therapeutics-Reports-Third-Quarter-2020-Financial-Results-and-Provides-Business-Update-1029795792"
type: article
quality: 42
heat: 42
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

secured: "iHCq4vOi089I2uN338Mf5vgMLfyBWPfZvZrx1Yg5R754uQAn8nO5RL2/jIrSZKHaGgK6OEztPWoj+2paJL6HvgV42t9DPpVqIhlGpbdOIIWxIn3lDwOlvA/2rT14xDEKno7BZ3MLVQ02uitDBHu5BG74dx3reTwhbyPRrF3pUpayTXDB3zdyAMhOWmg+wImhK9jZgtKPuOZa/DS8BKuNLpkbgaZtTgmKulFrnPQ/oIf+ATcHvr2azqjhToWHjoKH+wso4XYqwhUrX3nca5AzUjlJKJQis5KqIco4WT3pRIYquMD/lGqdwsAyA66cWakJfmdbFN18usjNLiO7COLcSAroP+YBi407EKL3x2ujeXE=;6lKNjTnBl6B36DBQXicTfw=="
---

